Metal Compounds in Cancer Therapy
Seiten
1994
|
and ed.
Chapman and Hall (Verlag)
978-0-412-54280-0 (ISBN)
Chapman and Hall (Verlag)
978-0-412-54280-0 (ISBN)
The discovery of the anti-tumour activity of cisplatin in 1965, and its subsequent introduction into clinical trials in 1971, was the catalyst for a major research effort into the potential of metal compounds in cancer therapy. This book provides a discussion of metal compounds in cancer therapy. This book should be of interest to research workers in the pharmaceutical industry, particularly tumour pharmacologists, tumour biologists, medicinal chemists and oncologists.
Introduction, S.P. Fricker. Platinum Anti-Cancer Drugs L.R. Kelland. Gold, F. Shaw III. Ruthenium Compound in Cancer Therapy, G. Sava. Rhodium, Iridium and Palladium Compounds as Experimental Anticancer Drugs, G. Buckley. Organometallic Titanium, Vanadium, Niobium, Molybdenum and Rhenium Complexes - Early Transition Metal Anti-Tumour Drugs, P. Kopf-Maier and H. Kopf. Anti-tumour Activity of Tin Compounds, A.J. Crowe. Gallium Compounds in Cancer Therapy, P. Collery. Bleomycin and Metal Interactions, J.M.C. Gutteridge. The In Vivo use of Metallic Radioisotopes in Cancer Detection and Imaging, D.J. Hnatowich.
Reihe/Serie | Metals in Health & Disease S. ; v. 1 |
---|---|
Zusatzinfo | 93 line illustrations, 2 halftones, index |
Verlagsort | London |
Sprache | englisch |
Maße | 156 x 234 mm |
Gewicht | 480 g |
Einbandart | gebunden |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Pharmazie | |
ISBN-10 | 0-412-54280-3 / 0412542803 |
ISBN-13 | 978-0-412-54280-0 / 9780412542800 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Handbuch für die Pflegepraxis
Buch | Softcover (2023)
Springer (Verlag)
39,99 €